Delivery Order SPE2DB25D3504-SPE2DB25FVUXD
- Not listed
- The Defense Logistics Agency awarded a $14,127.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of September 23, 2025. This is a non-set-aside contract issued to the Corporate Office division of the company, headquartered in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement under AmerisourceBergen's larger federal contract portfolio with the Defense Logistics...
- The Defense Logistics Agency awarded a $4,476.48 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of September 3, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $41,926.99 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical supply. This non-competitive delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a child contract under AmerisourceBergen's larger federal pharmaceutical supply vehicle. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.72 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical supply transaction under the company's broader relationship with the federal...
- The Defense Logistics Agency awarded a $32,686.99 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on June 20, 2025, with an ultimate completion date of June 23, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $15,400.75 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,265.90 delivery order on July 18, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls, with completion scheduled for July 21, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $10,610.60 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 MG/0.4 MLS on June 17, 2025, with a ceiling value of $3,095.26. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open federal procurement. The drug will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. This award represents a routine...
- The Defense Logistics Agency awarded a $63,341.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies. The contract was competitively awarded without set-aside provisions and is scheduled for completion by September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVUXDDelivery Order
The Defense Logistics Agency awarded a $2,795.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, with a completion date of June 2, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationships with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary operations supporting federal medical procurement. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The SPE2DX IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceutical products, specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's contract portfolio demonstrates established capability in fulfilling federal medical supply requirements through open competition, with orders spanning multiple therapeutic domains across diverse price points.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 5/30/25 |